Circadian Depression: How Sleep Timing Might Influence Antidepressant Response and Personalised Treatments

A Australian study analyzed 11,380 people with severe or recurring depression and proposed a circadian depression subtype defined by sleep timing patterns. Those with the circadian pattern reported less benefit and more side effects from common antidepressants (SSRIs and SNRIs), though some still benefited. The work connects internal timing to mood through brain systems and metabolism, and points to possible personalised approaches such as monitoring circadian timing and using light therapies in the future. While preliminary, the findings open questions about tailoring treatment to an individual’s body clock.

• Circadian rhythm disruptions may influence antidepressant response and side effects.
• Sleep timing features could help identify who might benefit from clock-targeted therapies.
• Light therapy could shift the body clock and improve mood, with caveats for bipolar disorder.
• Measuring internal timing with wearables or melatonin onset timing may guide future personalised treatment.

Overview

The article discusses how the body’s internal clock, or circadian rhythm, coordinates roughly 24-hour cycles affecting sleep, temperature, hormones, and mood. A large Australian study of 11,380 people with predominantly severe or recurrent depression explored whether distinct circadian-based patterns could explain why antidepressants work differently across individuals. About 23% of participants met criteria for a proposed circadian depression subtype, defined by a cluster of sleep timing features that align with a delayed internal clock. The researchers’ aim is to see whether these rhythms influence treatment outcomes and could lead to more personalised therapies.

The circadian depression concept

The proposed subtype is named circadian depression after the body’s roughly 24-hour clock. Participants needed at least three of six features: being a night owl, sleeping longer during depressive episodes, morning tiredness, seasonal changes in mood or behavior, habitually sleeping and waking later, and having different sleep schedules on workdays versus days off. These features collectively describe a pattern of delayed or irregular timing that misaligns with social schedules, a situation that may interact with mood regulation systems in the brain.

Findings on antidepressants and biology

Compared with other participants, those in the circadian group reported less improvement and more side effects from SSRIs and SNRIs. However, some people in this group still benefited from these medications. Genetic associations were also found with later sleep timing, reduced insulin sensitivity, and a protein linked to inflammation; the authors caution that these associations reflect inherited tendencies rather than clinical blood-sugar problems or systemic inflammation. Importantly, the study is observational and cannot establish causation.

Limitations and context

Several caveats accompany the findings. Symptoms and medication experiences were self-reported, and internal clocks were not directly measured in participants. The study did not establish cause and effect, and all participants identified were of European ancestry, limiting generalisability. As such, the 23% circadian depression figure should not be assumed to apply to all individuals with depression or across diverse populations. Nevertheless, the work highlights a potential direction for personalised psychiatry that could integrate timing information with pharmacology.

Could light therapy help?

Light therapy, which uses bright light boxes at scheduled times (often in the morning), can shift a late-running body clock earlier, promoting earlier sleep and wake times. It is established for seasonal affective disorder and shows promise for non-seasonal depression, though evidence remains inconclusive about a specific circadian subtype. A recent review of 11 clinical trials across non-seasonal depression found that remission rates with bright light were higher than with dim light or no bright light, but these trials did not select for circadian subtype, so they cannot determine whether circadian depression patients benefit more. Light may influence mood through pathways beyond the body clock as well, underscoring the need for careful clinical guidance, particularly for people with bipolar disorder where timing and mood shifts require supervision.

Timings, melatonin, and daily rhythms

Beyond light therapy, maintaining regular waking times, daytime activity, and meals can support daily rhythms. Melatonin timing may help shift a delayed clock, but studies have not established melatonin supplements as a depression treatment. Clinicians typically weigh risks and benefits, particularly in mood disorders, and timing becomes a crucial factor in treatment planning.

Towards more personalised treatment

The article discusses potential diagnostic tools to measure internal timing, including wrist-worn activity monitors to estimate sleep patterns and saliva melatonin onset to directly gauge timing. The central challenge remains to determine whether the proposed circadian group represents a distinct biological rhythm and whether tailoring treatment based on those measurements improves recovery times. At present, there is no justification to change antidepressants solely on sleep patterns without medical advice. If future trials confirm a benefit, future prescriptions for depression could specify when to receive light therapy as carefully as which medicine to take.